03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: NEU19<br />

MultiStage: No<br />

DXCat Label: Neurofibromatosis Type I [Von Recklinghausen's <strong>Disease</strong>] Specificity: A<br />

Etiology:<br />

Genetic (or hereditary)<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

1.01 Nuerofibromatosis Type I Neurofibromatosis Type I [genetic analysis report]<br />

DX 23770-23772;<br />

OR cutaneous neurofibromatosis [operative/pathology report]<br />

OR subcutaneous neurofibromatosis [operative/pathology report]<br />

OR Autosomal dominant, chromosome 17, gene codes for neurofibromin [genetic analysis<br />

report]<br />

OR Two or more of the following must be present:<br />

cafe-au-lait spot ≥ 1.5 cm in diameter for age > 13 years old<br />

OR cafe-au-lait spot ≥ 0.5 cm in diameter for < age 13 years old<br />

AND total of ≥ 6 cafe-au-lait spots<br />

OR ≥ two neurofibromas of any type<br />

OR ≥ 1 plexiform neurofibroma<br />

OR freckling in the axillary and inguinal regions<br />

OR ≥ 1 optic pathways glioma<br />

OR ≥ 2 Lisch nodules (iris amartomas)<br />

OR osseous lesion, such as sphenoid wing dysplasia or thinning of the cortex of long<br />

bones<br />

OR a first-degree relative with NF1 by the above criteria<br />

2.01 with paresthesias or hypesthesia Stage 1.01<br />

AND paresthesias<br />

OR hypesthesia<br />

2.02 with macroencephaly or learning disability Stage 1.01-2.01<br />

AND learning disability<br />

OR head diameter ≥ 95th percentile<br />

2.03 with pheochromocytoma or medullary Stage 1.01-2.02<br />

thyroid carcinoma or dysplastic scoliosis or AND sarcomatous degeneration [operative/pathology report]<br />

rhabdomyosarcoma or sarcomatous<br />

OR neurofibrosarcoma [operative/pathology report]<br />

degeneration<br />

OR malignant schwanomma [operative/pathology report]<br />

OR pheochromocytoma [operative/pathology report]<br />

OR medullary thyroid carcinoma [operative/pathology report]<br />

OR dysplastic scoliosis [operative/pathology report]<br />

OR rhabdomyosarcoma [operative/pathology report]<br />

3.01 with hemiparesis or paraparesis Stage 1.01-2.03<br />

AND hemiparesis<br />

OR paraparesis<br />

3.02 with hemiplegia or paraplegia Stage 1.01-3.01<br />

AND hemiplegia<br />

OR paraplegia<br />

STAGE 1.01 + DX 7820;<br />

STAGE 1.01-2.01 + (DX 3152,<br />

7424);<br />

STAGE 1.01-2.02 + (DXCAT END15<br />

OR DXCAT END14 OR DX 73743,<br />

1710-1719, 2150-2159);<br />

STAGE 1.01-2.03 + (DX 34200-<br />

34202, 34210-34282, 34290-<br />

34292, 3441);<br />

NO;<br />

Thursday, January 07, 2010 9:22:50 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!